Zollikofen, Switzerland

Andreas Kammer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Haberlimatteweg, CH (2013)
  • Zollikofen, CH (2013 - 2014)

Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andreas Kammer

Introduction

Andreas Kammer is a notable inventor based in Zollikofen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and adjuvant systems. With a total of 3 patents, his work has the potential to impact cancer treatment and immunology.

Latest Patents

One of his latest patents is the "Multiepitope vaccine for Her2/neu-associated cancers." This invention includes fusion peptides comprising fragments of the cancer-related protein Her2/neu. It outlines methods for preparing these fusion peptides, as well as virosomes that incorporate them. The applications of this invention focus on the prevention, treatment, or amelioration of cancers characterized by the expression or over-expression of the Her2/neu protein. Another significant patent is the "Trans-adjuvant system," which relates to a novel adjuvant system designed to generate an efficient immune response against various antigens. This system aims to reduce the risk of toxic side effects associated with known adjuvants. The innovative adjuvant comprises virosomes and facilitates the binding or encapsulation of antigenic molecules in delivery vehicles that are easier to prepare.

Career Highlights

Throughout his career, Andreas Kammer has worked with prominent companies in the biotechnology sector, including Pevion Biotech AG and Pevion Biotech Ltd. His expertise in vaccine development and immunology has positioned him as a valuable contributor to the field.

Collaborations

Andreas has collaborated with notable professionals such as Rinaldo Zurbriggen and Mario Amacker. These partnerships have further enhanced his research and development efforts in biotechnology.

Conclusion

Andreas Kammer's innovative work in vaccine development and adjuvant systems showcases his commitment to advancing medical science. His contributions have the potential to significantly improve cancer treatment and immunological responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…